Safety case processing could make SUSAR timelines obsolete
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Safety case processing could make SUSAR timelines obsolete
AI strengthens scalability in pharma while preserving control
Who’s really in charge in the NHS? Navigating a disrupted system
Cost of pharma’s unsustainable change management
Why is pharma so determined to give AI to patients?
How to turn medical insights into patient impact
GLP-1 – why faster progress won’t fix pharma’s challenges
Patients are missing strategy – pharma must seize the day